옥시토신 제제 시장 : 적응증별, 투여 경로별, 유래별, 최종 사용자별, 지역별 - 규모, 점유율, 전망, 기회 분석(2023-2030년)
Oxytocic Pharmaceuticals Market, By Indication, By Route of Administration, By Source of Origin (Synthetic Oxytocin, and Natural Oxytocin ), By End User, and By Region - Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030
상품코드
:
1304407
리서치사
:
Coherent Market Insights
발행일
:
2023년 06월
페이지 정보
:
영문
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
옥시토신 제제는 정상적인 출산을 위해 분만 유도 시 자궁 수축을 자극하고 산후 출혈을 억제하기 위해 정맥 또는 근육 내로 투여합니다. 옥시토신 제제의 투여는 산후 출혈을 예방하고 치료하는 데 도움이 됩니다. 옥시토신은 산후 출혈을 억제하는 데도 사용됩니다. 또한 임신을 종결하기 위해 다른 약물이나 시술과 함께 사용되기도 합니다. 옥시토신은 옥시토신 호르몬이라는 약물 그룹에 속합니다. 자궁 수축을 자극하여 작용합니다. 옥시토신은 병원이나 클리닉에서 의사나 의료 서비스 제공업체가 정맥 또는 근육 내로 투여하는 용액(액체)으로 제공됩니다. 진통을 유도하거나 진통을 강화하기 위해 옥시토신을 주사하는 경우, 보통 병원에서 의사의 감독 하에 정맥으로 주사합니다. 미국산부인과학회(ACOG)에 따르면, 자궁 무력증을 예방하기 위해 자궁 강장제를 예방적으로 투여하는 것이 권장됩니다. 또한, 진통 유도를 이용한 출산 증가는 예측 기간 동안 세계 강심제 시장의 성장을 가속할 것으로 예상됩니다.
시장 역학
주요 시장 기업들은 자궁수축제 시장 개척을 위해 제휴 및 인수와 같은 성장 전략을 채택하는 데 주력하고 있으며, 이는 세계 옥시토신 제제 시장의 성장에 기여하고 있습니다.
본 조사의 주요 특징
- 이 보고서는 세계 옥시토신 의약품 시장을 심층 분석하고, 2022년을 기준연도로 하여 예측 기간(2023-2030년) 시장 규모와 연평균 성장률(CAGR)을 제공합니다.
- 또한 다양한 부문의 잠재적 수익 기회를 파악하고 이 시장에 대한 매력적인 투자 제안의 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략 등에 대한 주요 고찰도 제공합니다.
- 세계 옥시토신 제제 시장의 주요 기업을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략과 같은 매개 변수를 기반으로 프로파일링합니다.
- 이 보고서의 주요 기업으로는 Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, EVER Pharma. 등이 있습니다.
- 이 보고서의 통찰력을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형화, 시장 확대 및 마케팅 전술에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- 세계 옥시토신 제제 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자는 세계 옥시토신 제제 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 내릴 수 있습니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 상황 개요
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 영향 분석
- 최근의 제품 출시
- 역학
- 합병, 인수, 제휴
- 규제 시나리오
- 주요 발전
- PEST 분석
제4장 세계의 옥시토신 제제 시장 - COVID-19의 영향 분석
- 경제적 영향
- COVID-19 역학
- 수급에 대한 영향
제5장 세계의 옥시토신 제제 시장 : 적응증별, 2018년-2030년
- 부전 유산
- 진행 유산
- 분만 후 출혈
- 진통 촉진제
- 진통 정지제
제6장 세계의 옥시토신 제제 시장 : 투여 경로별, 2018년-2030년
제7장 세계의 옥시토신 제제 시장 : 유래별, 2018년-2030년
- 합성 옥시토신
- 천연 옥시토신(동물 하수체 추출물)
제8장 세계의 옥시토신 제제 시장 : 최종사용자별, 2018년-2030년
제9장 세계의 옥시토신 제제 시장 : 지역별, 2018년-2030년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 멕시코
- 아르헨티나
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양 국가
- 중동
- GCC
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 중앙아프리카
- 북아프리카
제10장 경쟁 구도
- 기업 개요
- Fresenius Kabi AG
- Biofutura SpA
- Baxter Healthcare Corporation
- Pfizer Inc.
- Ferring B.V.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Abbott
- AdvaCare Pharma
- EVER Pharma
제11장 섹션
LSH
영문 목차
Oxytocic drugs are administered intravenously and intramuscularly to stimulate uterine contractions during labor induction for normal child birth and control bleeding after childbirth. Administration of Oxytocic drugs help in both prevention and treatment of postpartum hemorrhage. Oxytocin also is used to reduce bleeding after childbirth. It also may be used along with other medications or procedures to end a pregnancy. Oxytocin is in a class of medications called oxytocic hormones. It works by stimulating uterine contractions. Oxytocin comes as a solution (liquid) to be given intravenously (into a vein) or intramuscularly (into the muscle) by a doctor or healthcare provider in a hospital or clinic. If oxytocin injection is given to induce labor or to increase contractions, it is usually given intravenously with medical supervision in a hospital. According to the American College of Obstetricians and Gynecologists (ACOG) prophylactic administration of uterotonic agents to prevent uterine atony is recommended. Furthermore, increasing childbirth using labor induction is expected to boost growth of the global oxytocic pharmaceuticals market over the forecast period.
Market Dynamics
The key market players are focusing on adoption of growth strategies such as partnership and acquisitions, to bring in the development of uterine contractility drugs which is attributed to the growth of global oxytocic pharmaceutical market. For instance, in February 2022, Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, announced that it has entered into a sponsored research agreement with Inserm Transfert, the private subsidiary of Inserm, on behalf of Inserm (the French National Institute of Health and Medical Research) and Aix-Marseille Universite to study oxytocin in the genetically engineered mouse model of Prader-Willi syndrome, a rare genetic disorder that causes distinct, but related pathological eating disorders in adults and newborns. In adults, Prader-Willi causes hyperphagia, or pathological over-eating, which leads to obesity and other complications associated with significant mortality. In newborns, Prader-Willi causes a deficiency in suckling, which has been shown to be normalized by oxytocin treatment.
Key features of the study:
- This report provides an in-depth analysis of the global oxytocic pharmaceuticals market and provides market size (US$ Million) and Compound Annual Growth Rate (CAGR) for the forecast period (2023-2030), considering 2022 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global oxytocic pharmaceuticals market based on the following parameters-Company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer, Inc., Ferring B.V., Novartis AG, Teva Pharmaceuticals Industries Ltd., Abbott Laboratories, AdvaCare Pharma, and EVER Pharma.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- Global oxytocic pharmaceuticals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global oxytocic pharmaceuticals market
Detailed Segmentation:
- Global Oxytocic Pharmaceuticals Market, By Indication:
- Abortion Induced Incomplete
- Inevitable Abortion
- Postpartum Hemorrhage
- Labor Induction
- Labor Arrest
- Global Oxytocic Pharmaceuticals Market, By Route of Administration:
- Intramuscular
- Intravenous Injection/Infusion
- Global Oxytocic Pharmaceuticals Market, By Source of Origin:
- Synthetic Oxytocin
- Natural Oxytocin (Animal Pituitary Extract)
- Global Oxytocic Pharmaceuticals Market, By End User:
- Hospitals
- Maternity Clinics
- Global Oxytocic Pharmaceuticals Market, By Region:
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Fresenius Kabi AG *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Biofutura SpA
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Baxter Healthcare Corporation
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Pfizer Inc.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Ferring B.V.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Abbott
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- AdvaCare Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- EVER Pharma
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Indication
- Market Snippet, By Route of Administration
- Market Snippet, By Source of Origin
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Recent Product Launches
- Epidemiology
- Merger, Acquisition, and Collaborations
- Regulatory Scenario
- Key Developments
- PEST Analysis
4. Global Oxytocic Pharmaceuticals Market - COVID-19 Impact Analysis
- Economic Impact
- COVID-19 Epidemiology
- Impact on Supply and Demand
5. Global Oxytocic Pharmaceuticals Market, By Indication, 2018 - 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Abortion Induced Incomplete
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Inevitable Abortion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Postpartum Hemorrhage
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Labor Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Labor Arrest
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
6. Global Oxytocic Pharmaceuticals Market, By Route of Administration, 2018 - 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
- Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
- Intravenous Injection/Infusion
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Mn)
7. Global Oxytocic Pharmaceuticals Market, By Source of Origin, 2018 - 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Synthetic Oxytocin
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
- Natural Oxytocin (Animal Pituitary Extract)
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
8. Global Oxytocic Pharmaceuticals Market, By End User, 2018 - 2030 (US$ Mn)
- Introduction
- Market Share Analysis, 2023 and 2030(%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
- Hospitals
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
- Maternity Clinics
- Introduction
- Market Size, Volume and Forecast, and Y-o-Y Growth, 2018 - 2030, (US$ Million)
9. Global Oxytocic Pharmaceuticals Market, By Region, 2018 - 2030, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2023 and 2030(%)
- Y-o-Y Growth Analysis, For Regions, 2018-2030
- North America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Indication, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Source of Origin, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By End User, 2018 - 2030, (US$ Mn)
- Market Size and Forecast, By Country, 2018 - 2030, (US$ Mn)
- South Africa
- Central Africa
- North Africa
10. Competitive Landscape
- Company Profiles
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Baxter Healthcare Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
11. Section
- References
- Research Methodology
- About us and Sales Contact
관련자료
